INBS Q1 2025 Earnings WiderThanExpected Loss as Revenue Remains Absent WIMI Q4 2020 Earnings EPS Misses Estimates Amid Slight Stock Decline ALIT Q1 2026 Earnings EPS Surprises 34 Above Estimates Stock Edges Higher PALI Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges BioLineRx Ltd BLRX Q3 2024 Earnings Narrowed Losses and Pipeline Progress Amidst Low Revenue Palantir Q1 2026 Earnings EPS Surpasses Estimates Revenue Details Unavailable Stock Edges Lower